Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Elisabeth Bergen"'
Autor:
Orsolya Rajky, Rupert Bartsch, Ruth Exner, Kristina Tendl-Schulz, Matthias Preusser, Ariane Steindl, Karin Dieckmann, Barbara Kiesel, Zsuzsanna Bago-Horvath, Petra A. Mercea, Guenther G. Steger, Florian Fitzal, Georg Widhalm, Elisabeth Bergen, Anna S. Berghoff
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 29:728-733
Background Androgen receptor (AR) expression is a potential therapeutic target in breast cancer (BC) as it is frequently expressed in the luminal A and B subtypes and in approximately one third of basal-like cancers. As AR-positive BC displays a dist
Autor:
Elisabeth Bergen
Publikováno v:
memo - Magazine of European Medical Oncology. 14:176-179
SummaryAt the ESMO (European Society for Medical Oncology) 2020 several interesting albeit not practice-changing studies in the field of pancreatic cancer were presented. The Canadian phase II randomized PA.7 trial investigated the additional benefit
Autor:
Elisabeth Bergen, Rupert Bartsch
Publikováno v:
memo - Magazine of European Medical Oncology. 12:308-311
Summary At the 2019 ASCO (American Society of Clinical Oncology) Annual Meeting, several interesting trial results were presented in the field of HER2-positive metastatic breast cancer. The end-of-study analysis of the pivotal CLEOPATRA trial indicat
Autor:
P. Scherleitner, P. Ferreira, Elisabeth Bergen, Barbara Kiesel, Anna S. Berghoff, Georg Widhalm, Matthias Preusser, Karin Dieckmann, Christian Müller, Gerald W. Prager
Publikováno v:
ESMO Open
Background Brain metastases (BM) are a rare complication in colorectal cancer (CRC) patients and associated with an unfavorable survival prognosis. Primary tumor side (PTS) was shown to act as a prognostic and predictive biomarker in several trials i
Autor:
Robert M. Mader, Ruth Exner, Karin Dieckmann, Matthias Preusser, Christoph C. Zielinski, Florian Fitzal, Elisabeth Bergen, Mela Medjedovic, Zsuzsanna Bago-Horvath, Guenther G. Steger, Anna S. Berghoff, Michael Gnant, Rupert Bartsch, Margaretha Rudas
Publikováno v:
Clinical Cancer Research. 25:2737-2744
Purpose:Brain metastases (BMs) are a rare but devastating condition in estrogen receptor (ER)–positive metastatic breast cancer (MBC). Although endocrine therapy (ET) is the mainstay of treatment in this disease subtype, only case reports have been
Autor:
Richard Greil, Elisabeth Bergen, Georg Pfeiler, R. Bartsch, Christoph Minichsdorfer, Florian Fitzal, S Frantal, Günther G. Steger, Viktor Wette, Ruth Exner, Daniel Egle, H Fohler, Marija Balic, M. Gnant
Publikováno v:
Cancer Research. 79:P6-21
This abstract was withdrawn by the authors. Citation Format: Minichsdorfer C, Bergen E, Steger GG, Pfeiler G, Frantal S, Greil R, Fohler H, Egle D, Balic M, Fitzal F, Wette V, Exner R, Bartsch RA, Gnant M. Withdrawn [abstract]. In: Proceedings of the
Publikováno v:
memo - Magazine of European Medical Oncology. 12:63-66
While immunotherapy (IOT) with monoclonal antibodies has long been present in HER2-positive breast cancer, the development of modern IOT concepts such as PD-1/PD-L1 targeting immune checkpoint inhibitors has been slow compared with other malignancies
Autor:
Rupert Bartsch, Elisabeth Bergen
Publikováno v:
Memo
Summary At the 2018 ASCO Annual Meeting, data from several interesting studies in HER2-positive metastatic breast cancer were presented. While not immediately practice changing, these trials indicate the future directions of drug development in this
Autor:
Rupert Bartsch, Gerwin Heller, Barbara Kiesel, Kristina Tendl-Schulz, Ruth Exner, Johannes Leitner, Florian Fitzal, Julia Furtner, Elisabeth Bergen, Matthias Preusser, Karin Dieckmann, Zsuzsanna Bago-Horvath, Amelie Binter, Georg Widhalm, Anna S. Berghoff, Angelika M. Starzer
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and pertuzumab (TP) is a standard therapy of metastatic and localized HER2-positive breast cancer (BC), but its activity in breast cancer brain metastases (BCB
Autor:
Elisabeth Bergen, Rupert Bartsch
Publikováno v:
Memo
Summary In the areas of chemotherapy, targeted therapy and immunotherapy, several interesting and clinically relevant data were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS). This short review focuses on dose-dense and/or sequenti